What is the typical dosage for Quillichew ER?
The recommended starting dose for Quillichew ER is 10 mg once daily [1]. For individuals not currently taking aripiprazole, a dose of 5 mg once daily is suggested [1]. For those switching from other aripiprazole formulations, the dose should be equivalent to their current daily aripiprazole dose [1].
How is Quillichew ER administered?
Quillichew ER is a chewable tablet and should be taken once daily, with or without food [1]. It is designed for oral administration [1].
When does Quillichew ER patent exclusivity expire?
Drug patent information, including exclusivity expiry dates, is available through resources like DrugPatentWatch.com [2]. While specific patent expiry dates for Quillichew ER are not detailed here, such information can generally be found through specialized patent databases.
What is the active ingredient in Quillichew ER?
The active ingredient in Quillichew ER is aripiprazole [1]. Aripiprazole is an atypical antipsychotic medication [1].
What is Quillichew ER used to treat?
Quillichew ER is indicated for the treatment of schizophrenia in adult and pediatric patients [1]. It is also used for the treatment of bipolar I disorder in adults and pediatric patients aged 10 years and older as both monotherapy and an adjunctive therapy [1]. Additionally, it is used as an adjunctive treatment for major depressive disorder in adults [1].
What are the dosage adjustments for Quillichew ER?
Dosage adjustments may be necessary based on individual patient response and tolerability. For schizophrenia, the recommended maintenance dose for adults is typically between 10 mg and 15 mg once daily [1]. In bipolar I disorder, the target dose for manic or mixed episodes is 30 mg once daily [1]. For adjunctive treatment of major depressive disorder, the target dose is 15 mg once daily [1].
What are the potential side effects of Quillichew ER?
Common side effects of Quillichew ER include nausea, vomiting, constipation, headache, dizziness, and restlessness [1]. More serious side effects can include an increased risk of stroke in elderly patients with dementia-related psychosis, tardive dyskinesia, and neuroleptic malignant syndrome [1].
How does Quillichew ER compare to other aripiprazole formulations?
Quillichew ER is an orally disintegrating tablet formulation of aripiprazole, offering an alternative for patients who may have difficulty swallowing traditional tablets or capsules [3]. The therapeutic effect and active ingredient remain the same as other aripiprazole products [3].
What is the availability of generic aripiprazole?
Generic versions of aripiprazole are available [4]. The availability of generics can impact the market for branded formulations like Quillichew ER.
What is the role of patents in drug pricing?
Drug patents grant manufacturers exclusive rights to produce and sell a drug for a specified period. This exclusivity typically allows for higher pricing, which then generally decreases with the introduction of generic alternatives after patent expiry [2].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/